Expansion of the clinicopathological and mutational spectrum of Perry syndrome

Parkinsonism and Related Disorders

Volumn 20, Issue 4, 2014, Pages 388-393

  Chung, Eun Joo ^a   Hwang, Ji Hye ^b   Lee, Myung Jun ^c   Hong, Jeong Hoon ^d   Ji, Ki Hwan ^a   Yoo, Woo Kyoung ^e,f   Kim, Sang Jin ^a   Song, Hyun Kyu ^g   Lee, Chong S ^b   Lee, Myung Sik ^c   Kim, Yun Joong ^d,e,f  

^a Inje University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Hallym University   (South Korea)

^e Hallym University College of Medicine   (South Korea)

^f Hallym University Medical Center   (South Korea)

^g Korea University   (South Korea)

Author keywords

DCTN1; MR volumetry; Novel mutation; Perry syndrome; Positron emission tomography

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DOPAMINE TRANSPORTER; FLUORODEOXYGLUCOSE F 18; LEVODOPA; N 3 FLUOROPROPYL 2 BETA CARBOXYMETHOXY 3 BETA (4 IODOPHENYL)NORTROPANE F 18; PRAMIPEXOLE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DYNACTIN; MICROTUBULE ASSOCIATED PROTEIN;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRADYKINESIA; BRAIN ATROPHY; CASE REPORT; CAUDATE NUCLEUS; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DYNACTIN 1 GENE; FAMILY HISTORY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HYPERCAPNIA; INFERIOR PARIETAL LOBULE; MALE; MESENCEPHALON; MIDDLE AGED; MUSCLE RIGIDITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEOTIDE SEQUENCE; OCULOGYRIC CRISIS; ORBITAL CORTEX; PARKINSON DISEASE; PARKINSONISM; PARS OPERCULARIS; PERRY SYNDROME; PET SCANNER; POINT MUTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RESPIRATORY FAILURE; SEQUENCE ANALYSIS; SLEEP DISORDERED BREATHING; DEPRESSION; DIAGNOSTIC USE; GENETICS; HYPOVENTILATION; MOLECULAR GENETICS; MUTATION; PATHOLOGY;

BASE SEQUENCE; DEPRESSION; FEMALE; HUMANS; HYPOVENTILATION; MAGNETIC RESONANCE IMAGING; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84897965001     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.01.010     Document Type: Article

References (30)

1. Wider C., Wszolek Z.K. Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome) - a literature review. Parkinsonism Relat Disord 2008, 14:1-7.
2. Farrer M.J., Hulihan M.M., Kachergus J.M., Dächsel J.C., Stoessl A.J., Grantier L.L., et al. DCTN1 mutations in Perry syndrome. Nat Genet 2009, 41:163-165.
3. Perry T.L., Bratty P.J., Hansen S., Kennedy J., Urquhart N., Dolman C.L. Hereditary mental depression and parkinsonism with taurine deficiency. Arch Neurol 1975, 32:108-113.
4. Perry T.L., Wright J.M., Berry K., Hansen S., Perry T.L. Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome: clinical, biochemical, and neuropathologic studies of 2 new cases. Neurology 1990, 40:1882-1887.
5. Roy E.P., Riggs J.E., Martin J.D., Ringel R.A., Gutmann L. Familial parkinsonism, apathy, weight loss, and central hypoventilation: successful long-term management. Neurology 1988, 38:637-639.
6. Lechevalier B., Schupp C., Fallet-Bianco C., Viader F., Eustache F., Chapon F., et al. Familial parkinsonian syndrome with athymhormia and hypoventilation. Rev Neurol (Paris) 1992, 148:39-46.
7. Bhatia K.P., Daniel S.E., Marsden C.D. Familial parkinsonism with depression: a clinicopathological study. Ann Neurol 1993, 34:842-847.
8. Vilarino-Guell C., Wider C., Soto-Ortolaza A.I., Cobb S.A., Kachergus J.M., Keeling B.H., et al. Characterization of DCTN1 genetic variability in neurodegeneration. Neurology 2009, 72:2024-2028.
9. Saka E., Topcuoglu M.A., Demir A.U., Elibol B. Transcranial sonography in Perry syndrome. Parkinsonism Relat Disord 2010, 16:68-70.
10. Tsuboi Y., Wszolek Z.K., Kusuhara T., Doh-ura K., Yamada T. Japanese family with parkinsonism, depression, weight loss, and central hypoventilation. Neurology 2002, 58:1025-1030.
11. Wider C., Dachsel J.C., Farrer M.J., Dickson D.W., Tsuboi Y., Wszolek Z.K. Elucidating the genetics and pathology of Perry syndrome. JNeurol Sci 2010, 289:149-154.
12. Wider C., Dickson D.W., Stoessl A.J., Tsuboi Y., Chapon F., Gutmann L., et al. Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord 2009, 15:281-286.
13. Newsway V., Fish M., Rohrer J.D., Majounie E., Williams N., Hack M., et al. Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure. Mov Disord 2010, 25:767-770.
14. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000, 97:11050-11055.
15. Tzourio-Mazoyer N., Tran G.T., Schwarzlmuller T., Specht K., Haugarvoll K., Balafkan N., et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002, 15:273-289.
16. Oh M., Kim J.S., Kim J.Y., Shin K.H., Park S.H., Kim H.O., et al. Subregional pattern of preferential striatal dopamine transporter loss differs among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. JNucl Med 2012, 53:399-406.
17. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., et al. Amethod and server for predicting damaging missense mutations. Nat Methods 2010, 7:248-249.
18. Bjelic S., De Groot C.O., Scharer M.A., Jaussi R., Bargsten K., Salzmann M., et al. Interaction of mammalian end binding proteins with CAP-Gly domains of CLIP-170 and p150(glued). JStruct Biol 2012, 177:160-167.
19. Uyama E., Hirano T., Ito K., Nakashima H., Sugimoto M., Naito M., et al. Adult Chediak-Higashi syndrome presenting as parkinsonism and dementia. Acta Neurol Scand 1994, 89:175-183.
20. Jankovic J., Stone L. Dystonic tics in patients with Tourette's syndrome. Mov Disord 1991, 6:248-252.
21. FitzGerald P.M., Jankovic J., Percy A.K. Rett syndrome and associated movement disorders. Mov Disord 1990, 5:195-202.
22. Lee M.S., Kim Y.D., Lyoo C.H. Oculogyric crisis as an initial manifestation of Wilson's disease. Neurology 1999, 52:1714-1715.
23. Williams D.R., Hadeed A., al-Din A.S., Wreikat A.L., Lees A.J. Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov Disord 2005, 20:1264-1271.
24. Lechevalier B., Defer G., Rivrain Y., Le Doze F., Schupp C., et al. Perry and Purdy's syndrome (familial and fatal parkinsonism with hypoventilation and athymhormia). Bull Acad Natl Med 2005, 189:481-490.
25. Koenigs M., Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 2009, 201:239-243.
26. Benoit M., Robert P.H. Imaging correlates of apathy and depression in Parkinson's disease. JNeurol Sci 2011, 310:58-60.
27. Park H.K., Kim J.S., Im K.C., Oh S.J., Kim M.J., Lee J.H., et al. Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses. Mov Disord 2009, 24:237-245.
28. Tzoulis C., Tran G.T., Schwarzlmuller T., Specht K., Haugarvoll K., Balafkan N., et al. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain 2013, 136:2393-2404.
29. Varrone A., Salvatore E., De Michele G., Barone P., Sansone V., et al. Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism. Ann Neurol 2004, 55:426-430.
30. Womack K.B., Diaz-Arrastia R., Aizenstein H.J., Arnold S.E., Barbas N.R., Boeve B.F., et al. Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors. Arch Neurol 2011, 68:329-337.